Scientists uncover unexpected cancer target on tumor cell surfaces
For five decades, scientists have known about a notorious cancer-causing enzyme called SRC. But they always assumed it…
Real-world study shows modest weight regain after GLP-1 discontinuation
As the use of injectable GLP-1 drugs continues to rise, questions persist about what happens after patients stop…
BBC NHS GP on new warning for Fluoxetine, Sertraline and Citalopram users
A Queen’s University Belfast study has found increased mortality risks for some patients Dr Oscar Duke has shared…
Cannabis, cocaine and amphetamines linked to higher stroke risk
A massive analysis of more than 100 million participants reveals that several commonly used illicit substances may raise…
Targeting IGF2BP2 improves anti-angiogenic therapy effectiveness in colorectal cancer
A recent study published in Engineering has shed light on a novel therapeutic target for improving anti-angiogenic treatment…
FOXJ1 gene may drive resistance to taxane chemotherapy in advanced prostate cancer
A gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to…
“Bugs Delivering Drugs” – Researchers Publish New Approach To Colorectal Cancer Treatment Using Common Food-Borne Bacteria
Baylor University researchers have published a novel approach to fight colorectal cancer, using modified bacteria as a courier…
Could GLP-1 drugs help curb addiction? Large veteran study points to potential benefit
A major study of US veterans suggests that GLP-1 diabetes medications may influence addiction-related outcomes, revealing a surprising…
Engineered lettuce may turn injectable GLP-1 therapies into oral pills
Few drugs have entered mainstream awareness as quickly or as dramatically as glucagon-like peptide-1, or GLP-1 receptor agonists.…
UK recall of common blood pressure medication issued after major packaging mistake
All pharmacies and patients who use the widely prescribed medication have been told to urgently check the packagingCharlotte…
Ozempic-style GLP-1 drugs could slash complication risks after heart attacks, research suggests
A popular class of weight-loss drugs may prevent life-threatening cardiac complications by opening microscopic blood vessels that often remain blocked…
MSK uncovers how interacting mutations shield breast cancer
Researchers at Memorial Sloan Kettering Cancer Center (MSK) have made an important discovery about how genetic mutations in breast…